156 results
Page 4 of 8
424B3
EX-99.2
s54ovffb7k9r adkvtw
25 Feb 22
Prospectus supplement
8:39am
424B3
EX-99.1
hs8 niq77
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.1
13rz7wf je3af
25 Feb 22
Regulation FD Disclosure
8:38am
8-K
EX-99.2
858wdg60k9z27du6v868
25 Feb 22
Regulation FD Disclosure
8:38am
424B3
EX-99
bdc0i9
1 Dec 21
Prospectus supplement
8:25am
424B3
EX-99.1
vcbkcl7mn48wf7
1 Dec 21
Prospectus supplement
8:25am
8-K
m1rwex
1 Dec 21
Departure of Directors or Certain Officers
8:14am
8-K
EX-99.1
zzmc 0ylnf
1 Dec 21
Departure of Directors or Certain Officers
8:14am
8-K
EX-99.1
ub3uu22eouaanrn1h
19 Nov 21
Regulation FD Disclosure
8:09am
424B3
7a1zuh95 7aje5n471k4
12 Nov 21
Prospectus supplement
8:41am
424B3
7yvao 3m3z
28 Sep 21
Prospectus supplement
9:07am
8-K
eix6eexb
28 Sep 21
Entry into a Material Definitive Agreement
8:53am
8-K
EX-99.1
unovp u41j7tb
28 Sep 21
Entry into a Material Definitive Agreement
8:53am
424B3
tmjoybue 0bl
13 Aug 21
Prospectus supplement
5:25pm
8-K
EX-99.1
862b86r6n
13 Aug 21
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
7:00am
424B3
qkvr k2omh1x
5 Aug 21
Prospectus supplement
4:26pm
8-K
EX-3.2
gdgxm5
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am